Most Sold By Activist Hedge Funds
12.60k followers • 10 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stocks that were sold the most by activist hedge funds in the last quarter.
10 symbols
Get the Yahoo Finance app
- Free real-time data
- News and price alerts
- Add and edit holdings
- Track performance
- Create multiple watchlists
- Yahoo Finance
Lowe’s, Target, Nordstrom earnings — What to know in markets Wednesday
It's another retail earnings extravaganza Wednesday with Lowe's, Target and Nordstrom releasing results.
- Motley Fool
The Most Surprising Thing About Warren Buffett's Investing Strategy
Buffett's investing success relies on something that might come as a shock to most investors.
- Investing.com
Lowe’s Earnings, Revenue Beat in Q2
Investing.com - Lowe’s reported second quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
- Zacks
Bayer Sells Animal Health Division to Elanco: Now What?
On Tuesday, Bayer (BAYRY) announced the sale of its animal-health division to American competitor Elanco (ELAN), for a net price of $7.6 billion. The deal is expected to close in mid-2020 after regulatory approval.
- Zacks
Home Depot (HD) Shares Rise on Q2 Earnings Beat: What's Next for the Company?
Home Depot (HD) reported second quarter earnings before the opening bell, sending shares up over 4%.
- Reuters - UK Focus
US STOCKS-Wall Street rally ends as financial shares slide
Financial shares led U.S. stocks lower on Tuesday to end a three-day rally as investors awaited comments from Federal Reserve Chair Jerome Powell at the end of the week. The S&P 500 financial index dropped 1.4% and the group weighed most heavily on the benchmark index among its major sectors, which all registered losses. The S&P 500 is now 4.1% shy of its record closing high in July after having fallen as much as 6.2% below that level.
- Zacks
Trump & The Fed, Home Depot, Retail Worries & Buy Garmin Stock | Free Lunch
President Trump and Federal Reserve, Home Depot (HD) and TJX (TJX) earnings, a broader look at the retail industry amid the ongoing U.S.-China trade war, and why Garmin (GRMN) is a Zacks Rank 1 (Strong Buy) stock on this episode of Free Lunch.
- Zacks
Home Improvement Retailers Are Up To Bat
Home Depot's ability to navigate the rocky economic waters thus far in 2019 is a positive sign for the home improvement retail sector. Investors are beginning to price in positive results for Lowe???s imminent earnings tomorrow morning.
- Investing.com
Day Ahead: Top 3 Things to Watch
Investing.com - Here's a preview of the top 3 things that could rock markets tomorrow.
- Zacks
Why is Hold Strategy Apt for Discover Financial (DFS) Now?
Banking on growing revenues, strategic capital management and high card sales volume, Discover Financial (DFS) holds potential to benefit investors.
- Zacks
Euronet Launches Quick Response Application to Ease Payments
Euronet Worldwide (EEFT) assists the Commercial Bank of Ceylon to launch the first unique Quick Response (QR)-based payment application in Sri Lanka.
- Zacks
Can Growing Partner Base Aid salesforce's (CRM) Q2 Earnings?
salesforce's (CRM) second-quarter fiscal 2020 results are likely to gain from the growing adoption of its cloud offerings, aided by its expanding partner ecosystem.
- Zacks
The Zacks Analyst Blog Highlights: Microsoft, Merck, Walmart, Coca-Cola and Visa
The Zacks Analyst Blog Highlights: Microsoft, Merck, Walmart, Coca-Cola and Visa
- Reuters
Exclusive: Cigna seeks sale of group benefits insurance business - sources
Cigna's move to shed it underscores its decision to focus on healthcare following its $54-billion acquisition of pharmacy benefits manager Express Scripts Holding Co last year. The Bloomfield, Connecticut-based company is working with an investment bank to run an auction for the group benefits business, the sources said.
- Reuters - UK Focus
China adds 148 drugs to key insurance list - state media
BEIJING/SHANGHAI, Aug 20 (Reuters) - China on Tuesday added 148 drugs to its list of medicines covered by basic medical insurance schemes, part of a push to lower patients' out-of-pocket costs in one of the world's largest drug markets, state media reported. AstraZeneca's Kombiglyze and Merck & Co's Janumet diabetes treatments are among the drugs that will now be covered by national insurance, according to the updated list published by China's National Healthcare Security Administration. As it published the updated list of 2,643 drugs on its website on Tuesday, the healthcare administration said the adjustment was crucial to improving the efficient use of the country's medical insurance funds.
- Zacks
What Makes Cigna (CI) a New Buy Stock
Cigna (CI) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Motley Fool
Is Apple iPhoning the Finance Industry?
A new credit card exclusive to Apple customers is getting a lot of hype.
- Zacks
Another 1% Rally Provides a Strong Start to the Week
Another 1% Rally Provides a Strong Start to the Week
- Bloomberg
How an Obscure Rubber Company Became a Linchpin of Tech Industry
(Bloomberg) -- Terms of Trade is a daily newsletter that untangles a world embroiled in trade wars. Sign up here. When Japan decided to step up its fight with South Korea last month, it dug deep into the supply chain to impose sanctions on three obscure materials made by a handful of Japanese companies few have ever heard of.The most powerful weapon in Tokyo’s campaign against its neighbor turned out to be a half-dozen or so niche firms with names like JSR Corp., Shin-Etsu Chemical Co. and Tokyo Ohka Kogyo Co. They make fluorinated polyimide, hydrogen fluoride and photo-resist: essential ingredients for the manufacture of the displays and semiconductors that go into every piece of modern consumer electronics, from Apple Inc. iPhones and Dell Technologies Inc. laptops to the full range of Samsung Electronics Co. devices. Japan prohibited the export of those materials, allowing an exception only if suppliers secure a license and renew that license regularly.How did they become so indispensable? And how did they manage to stay on top even after their Japanese clients ceded the chip and display markets to Taiwanese and South Korean rivals? The answer lies in a series of well-timed investments decades ago, combined with a willingness to explore foreign markets and an unceasing refinement of manufacturing standards too exacting for anyone else to try and match.“JSR is an interesting case in that they became big in photo-resists because they succeeded overseas first,” said Damian Thong, an analyst at Macquarie Group Ltd. “And much of this success was because of the strategy of one man — Mitsunobu Koshiba.”The JSR chairman’s story shows just how hard it would be for a newcomer to fill the shoes of one of these suppliers. Koshiba spearheaded the company’s pivot into photo-resists, a light-sensitive liquid used to imprint circuits as narrow as a few strands of DNA onto silicon wafers in a process called lithography. Gadgets keep getting slimmer, more powerful and cheaper because chip companies are able to etch ever smaller circuit patterns onto silicon. When it comes to the most advanced chip processes, JSR is one of the few that can deliver the goods.When 25-year-old Koshiba joined JSR in 1981, the company’s biggest business was still tire rubber. (The name is an abbreviation of Japan Synthetic Rubber.) As luck would have it, photo-resist at that time used resins that JSR had access to for its existing business, and the company saw an opportunity to break into a new growth industry. Japanese semiconductor makers were just beginning their rise to global dominance, and suppliers were positioning themselves to go along for the ride.The problem for JSR was it didn’t belong to any of the local keiretsu, a grouping of suppliers that receives preferential access to contracts. And the company was also up against Tokyo Ohka or TOK, the first in Japan to manufacture photo-resist. By the mid-1980s, TOK controlled as much as 90% of the domestic market.“As a neutral company without keiretsu affiliations, we had to look outside Japan,” Koshiba said in an interview, outlining JSR’s decades-long rise but declining to talk in detail about sensitive trade negotiations now underway between Tokyo and Seoul.JSR’s decision to get into that market was bold but Koshiba seemed like the right person for the job. He’d spent two years studying materials science at the University of Wisconsin-Madison on a Rotary Club scholarship, was one of the few English speakers at the company and was eager to work abroad. In 1990, JSR sent him to Belgium to set up a photo-resist joint venture with the country’s biopharmaceutical giant UCB SA. The goal was to target the American market.As timing would have it, JSR was going overseas just as Japan was approaching the peak of its semiconductor prowess. That same year, NEC Corp., Toshiba Corp. and Hitachi Ltd. were the world’s biggest chipmakers, pushing aside Intel Corp. and Texas Instruments Inc. Japanese firms occupied six spots in the industry’s top 10 ranking by revenue, a level of concentration that hasn’t been matched by any country since, according to IC Insights.Japan’s seemingly unshakable control of the computer memory market gave the country renewed national confidence. The mood was reflected in the book “The Japan That Can Say No,” in which right-wing politician Shintaro Ishihara and Sony Corp. co-founder Akio Morita argued for a more muscular foreign policy. In an eerie echo of recent events, the authors contended that the Japanese government had the power to determine the outcome of the Cold War just by directing its national companies to sell the chips used in intercontinental ballistic missiles (ICBMs) to the Soviets instead of the U.S.But the Cold War ended before that theory could be tested. Over the following decade, personal computers overtook ICBMs as the primary destination for chips and demand shifted to prioritize low unit costs over military-spec quality. By 2006, Samsung had risen to No. 2 on the list of the world’s biggest chipmakers, with Korean compatriot SK Hynix Inc. ranking seventh and only three Japanese names remaining among the top 10.For JSR, the turning point came in 2000. Koshiba, who was based in California at that time, recalls being dragged into an emergency meeting on a Sunday wearing a T-shirt and shorts. Word was a rival company was about to clinch an agreement with IBM for joint research on a next-generation photo-resist material. “Get it back,” he was told. Koshiba leaned on the network of American industry contacts he had spent a decade building, people who had known him through the worst of U.S.-Japanese trade tensions. Within a month, IBM signed with JSR.“Without that deal, we wouldn’t have gotten to No. 1,” Koshiba said.In lithography, the formula for shrinking transistors has only two levers: increase the light power or use a lens that lets more light through. Every time the chip process shifts to a higher-energy band of light, resist makers have to go back to the drawing board, opening up new opportunity. The research partnership with IBM ushered in the fourth such shift since integrated circuits replaced vacuum tubes in the 1970s, and JSR rode it all the way to the top.The company now commands about 40% of the market for the latest generation of resist used in mass production. It also supplies more than 30% of the photo-resist for 3D NAND, the most advanced flash memory chips, which are among the few product lines where Japan still competes with Korean rivals. In 2019, JSR is expected to generate about three times the revenue and five times the profit it did in the early ‘90s.What makes this business inaccessible to newcomers is the extreme degree of purity and quality demanded by customers. TOK says a single drop of coffee in two Olympic-sized swimming pools would be considered an unacceptable defect. JSR’s analogy is to a handful of tainted golf balls being enough to spoil a batch the size of the entire Japanese archipelago.In addition to being technically challenging, the markets these companies operate in are small and don’t promise fantastic growth. According to research firm Fuji Keizai Group, the industry’s sales rose just shy of 8% last year to $1.3 billion. Koshiba jokes that even the market for ramen noodles is bigger than that.“To recreate JSR, you basically need to spend as much as they did in the past 20 years on R&D and relationships, and also rebuild their reputation,” Macquarie’s Thong said. “These materials are used in such moderate quantities that to rebuild the whole infrastructure is probably not worth the investment.”And that’s the irony of the current situation. By stoking trade tensions, Japan may encourage its neighbor to subsidize competition to JSR and TOK that wouldn’t make sense under normal market conditions. It’s a matter of survival: Korean corporations now depend on Japan for over 90% of all the fluorinated polyimide and resists they need, and 44% of hydrogen fluoride requirements, Societe Generale estimates.Read more: Japan Grants South Korea Export License, Lessening Trade FearsFor the time being, JSR and TOK retain dominance over one prized material that keeps the consumer electronics industry ticking. According to South Korean Prime Minister Lee Nak-yon, Japan has approved exports of photo-resist for the next-generation of lithography currently under development by Samsung and Taiwan Semiconductor Manufacturing Co. But one of Japan’s last strongholds of tech industry domination may be under threat.“They have the engineers, and once national pride is involved they can possibly make it even if it loses money,” Koshiba said. “We don’t have an impregnable wall.”\--With assistance from Jason Clenfield.To contact the reporters on this story: Pavel Alpeyev in Tokyo at palpeyev@bloomberg.net;Yuki Furukawa in Tokyo at yfurukawa13@bloomberg.netTo contact the editors responsible for this story: Peter Elstrom at pelstrom@bloomberg.net, Vlad Savov, Edwin ChanFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
- Zacks
What to Expect from Salesforce's (CRM) Q2 Earnings Thursday
Salesforce (CRM) stock is up 5.1% YTD, lagging behind the S&P 500???s 14% climb. Shares of Salesforce are also down roughly 14% from their 52-week highs. The customer relationship management firm is set to report its Q2 2020 earnings results after the close on Thursday, August 22.
- Zacks
Dell Technologies (DELL) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Dell Technologies (DELL) closed at $49.05, marking a +1.28% move from the previous day.
